Other congenital malformations of respiratory system

Q17_OTHER_CONGEN_MALFO_RESPI_SYSTEM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q34 Cause of death: ICD-10 — Q34 2 out of 7 registries used, show all original rules.	60
4. Check minimum number of events None	60
5. Include endpoints None	60
6. Filter based on genotype QC (FinnGen only)	60

Control definitions (FinnGen only)

Control exclude: Q17_CONGEN_MALFO_RESPI_SYSTEM

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q3[0-4]
Name in latin: Aliae malformationes congenitae systematis respiratorii

NAME	Q17_OTHER_CONGEN_MALFO_RESPI_SYSTEM
CONTROL_EXCLUDE	Q17_CONGEN_MALFO_RESPI_SYSTEM
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q34
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q34
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other congenital malformations of respiratory system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	457	225	232
Only index persons	393	196	197
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	-	43.31	33.85
Only index persons	45.30	46.54	44.08

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	60	35	25
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	42.70	43.79	41.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
55: Matched controls
548

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q34.1

ICD-10 Finland

Congenital cyst of mediastinum

+∞

46.6

UGC12

NOMESCO Finland

Flexible bronchoscopy

10.4

7.7

Q34.0

ICD-10 Finland

Anomaly of pleura

+∞

7.4

R4110

NOMESCO Finland

Physiotherapy

5.4

7.4

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

7.3

6.6

GEB30

NOMESCO Finland

Mediastinotomy and excision of lesion

78.6

6.6

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

78.6

6.6

R05

ICD-10 Finland

Cough

4.9

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000991) Gas panel - Venous blood

4.60

5.65

10.5

5.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4.38

5.33

2.4

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4.38

5.33

2.4

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3.93

5.02

2.7

2.1

—

(3032080) INR in Blood by Coagulation assay

144

3.17

4.58

7.7

6.3

1.17

1.12

inr

—

(3000494) Fungus identified in Specimen by Culture

3.83

4.48

1.1

1.5

—

(3042936) Bacteria identified in Isolate by Culture

3.59

4.43

1.1

2.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

8.18

4.00

1.3

2.0

—

(40768797) Stomach Pathology biopsy report

3.53

4.00

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

103

3.00

3.85

2.8

2.4

—

(3023368) Bacteria identified in Blood by Culture

111

2.94

3.78

6.4

4.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

166

2.79

3.71

3.0

4.2

37.48

29.32

u/l

0.38

158

(3044889) 12 lead EKG panel

317

3.23

3.58

3.5

3.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

10.91

3.58

1.5

1.3

—

(3012544) pH of Venous blood

3.42

3.47

5.6

9.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

5.97

3.31

1.9

2.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

4.85

3.14

9.3

7.5

94.41

94.03

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

6.44

3.12

1.3

1.9

—

(3002256) Pathology report gross observation

3.25

3.04

1.2

1.0

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4.62

3.02

9.0

7.3

0.58

0.74

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4.62

3.02

9.3

7.3

0.80

1.37

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.77

2.83

3.6

3.8

18.50

84.66

ng/l

0.86

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

8.94

2.80

3.8

8.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

8.94

2.80

1.4

1.8

—

(40758558) Short blood count panel - Blood

127

2.48

2.79

18.3

9.4

—

(3052851) Hemolysis interference index of Serum or Plasma

6.52

2.77

2.7

—

(4035726)

4.05

2.70

1.8

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

4.05

2.70

7.9

4.1

29.26

103.05

u/ml

—

(3020682) Albumin/Creatinine [Ratio] in Urine

115

2.44

2.60

4.0

3.7

7.15

11.56

mg/mmol

0.38

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

7.65

2.60

1.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

155

2.35

2.59

5.3

3.9

2.32

2.37

mmol/l

0.87

137

(3011397) Hemoglobin [Presence] in Urine by Test strip

116

2.42

2.54

3.9

2.9

—

(3006315) Basophils [#/volume] in Blood

246

2.31

2.49

9.8

8.4

0.04

e9/l

0.14

215

(3022948) Iron [Moles/volume] in Serum or Plasma

2.63

2.48

3.6

2.3

15.44

14.89

umol/l

0.07

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

166

2.29

2.47

8.5

3.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.42

2.46

1.2

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

219

2.28

2.46

3.8

4.1

—

(3001604) Monocytes [#/volume] in Blood

247

2.30

2.46

9.8

8.3

0.52

0.58

e9/l

0.91

217

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.59

2.42

1.3

2.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

6.69

2.42

1.2

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

6.69

2.42

1.2

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.85

2.36

7.6

8.0

—

(3044640) Blood type and Crossmatch panel - Blood

138

2.23

2.24

3.8

2.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.53

2.18

2.6

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2.55

2.14

4.0

2.3

2.23

2.54

g/l

1.20

(42870588) Differential panel, method unspecified - Blood

174

2.14

10.9

8.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3.02

2.03

1.7

1.3

—

(40768804) Tissue Pathology biopsy report

177

2.09

2.02

2.3

1.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3.26

2.02

1.6

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

4.04

1.99

2.0

4.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2.49

1.94

4.2

2.3

30.18

23.79

0.43

(3030467) Casts [#/volume] in Urine by Automated count

129

2.11

1.91

9.9

2.9

0.03

0.23

e6/l

3.04

(3018418) pH of Serum or Plasma

122

2.11

1.86

7.3

3.6

7.37

7.41

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

4.44

1.86

1.2

1.3

—

(36304419) Bacteria [Presence] in Urine

134

2.01

1.71

9.9

2.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

151

1.98

1.70

2.5

2.0

99.23

103.31

pmol/l

0.13

(3022096) Basophils/100 leukocytes in Blood

232

1.94

1.69

11.0

8.2

0.61

0.68

0.30

219

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.20

1.68

6.4

2.6

10.29

1.45

e6/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

291

1.97

1.67

18.5

12.6

4.01

3.76

e9/l

0.23

250

(3037467) Urinalysis macro (dipstick) panel - Urine

313

1.98

1.62

8.4

4.2

—

(3019060) Gas panel - Arterial blood

2.80

1.57

1.9

5.0

—

(3000492) Spirometry study

2.47

1.56

1.9

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.53

1.55

1.0

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

3.53

1.55

1.2

8.3

3.58

3.28

g/l

—

(3006504) Eosinophils/100 leukocytes in Blood

237

1.87

1.55

11.1

8.4

2.18

2.85

1.62

222

(3021589) Normoblasts [#/volume] in Blood

219

1.86

1.52

15.8

10.8

0.01

0.00

e9/l

0.48

178

(3019069) Monocytes/100 leukocytes in Blood

238

1.86

1.52

11.1

8.7

8.58

8.47

0.08

226

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.69

1.50

3.1

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

291

1.83

1.40

9.0

4.1

—

34.17

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2.56

1.35

4.9

1.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.99

1.34

6.3

2.5

0.50

0.99

e6/l

—

(3015736) pH of Urine

180

1.78

1.32

4.6

3.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2.93

1.31

1.8

6.9

159.80

159.67

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.41

1.30

1.4

1.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

247

1.75

1.27

11.1

8.3

28.47

30.96

0.50

232

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2.77

1.24

1.6

6.9

90.20

90.21

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.27

1.24

22.5

14.5

24.36

24.53

mmol/l

—

(3002582) Erythrocytes [#/volume] in Urine

148

1.77

1.21

10.1

2.9

26.45

20.69

e6/l

0.16

115

(3018095) Leukocytes [#/volume] in Urine

168

1.71

1.15

12.2

3.5

16.45

20.50

e6/l

0.15

119

(36660697) Celiac disease serology panel - Serum

2.11

1.14

1.3

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

108

1.80

1.12

1.9

1.6

1.63

2.19

g/l

1.35

(3021601) Nitrite [Presence] in Urine by Test strip

228

1.63

1.03

8.7

4.8

0.00

estimate

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2.11

0.90

4.3

2.6

—

(40761535) Cells panel - Urine sediment

2.11

0.90

2.3

2.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1.85

0.86

18.6

16.5

—

1.39

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.28

0.78

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.71

0.77

1.8

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.18

0.76

1.0

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.90

0.75

2.9

3.6

50.07

14.48

ug/l

—

(3037522) Nuclear Ab [Titer] in Serum

1.74

0.70

1.0

1.6

—

385.88

—

(1002224) Polysomnography panel

1.93

0.70

1.0

—

(3016879) Cocaine [Presence] in Urine

1.86

0.68

1.2

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

235

1.45

0.67

6.6

3.2

0.00

estimate

—

(3022313) Gas panel - Capillary blood

1.79

0.65

24.8

6.4

—

(3027944) Amphetamines [Presence] in Urine

1.79

0.65

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

431

1.57

0.64

25.8

10.5

91.38

87.02

ml/min/173m2

0.73

348

(3028300) Cannabinoids [Presence] in Urine

1.73

0.63

1.2

—

(40761536) Microorganisms panel - Urine sediment

1.73

0.63

13.2

2.9

—

(3000764) Benzodiazepines [Presence] in Urine

1.73

0.63

1.2

—

(3027008) Opiates [Presence] in Urine

1.73

0.63

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.61

0.0

1.7

—

345.28

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.54

0.61

3.2

2.1

—

(3026008) Bacteria identified in Urine by Culture

126

1.49

0.60

5.5

2.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.55

0.60

1.8

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

101

1.50

0.56

2.1

1.7

21.32

24.58

nmol/l

0.41

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.50

0.55

1.3

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

111

1.47

0.53

6.3

5.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.57

0.50

2.2

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.46

0.44

4.5

5.8

—

(3029937) Albumin [Presence] in Urine by Test strip

116

1.39

0.42

6.5

3.1

0.00

estimate

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.44

0.42

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.2

—

9.37

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.41

0.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.41

0.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.2

—

(4010399)

1.47

0.40

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

127

1.35

0.39

1.6

1.7

—

(3013512) EKG study

115

0.74

0.31

2.7

3.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1.22

0.26

1.2

1.7

437.26

516.34

pmol/l

—

(1761868) Lipid panel - Serum or Plasma

185

1.21

0.22

2.3

2.2

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.21

0.0

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.06

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

5.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.21

0.0

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.20

0.0

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

0.20

0.0

1.4

—

1.92

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.13

0.17

2.4

1.6

—

(3003694) ABO and Rh group [Type] in Blood

153

1.16

0.13

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

133

0.88

0.08

7.7

2.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.11

0.08

1.3

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

149

1.10

0.06

3.9

3.0

18.01

41.78

ng/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

383

0.98

0.00

4.6

3.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

2.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

180

1.00

0.00

5.9

3.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.02

0.00

2.5

1.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.2

—

44.43

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.0

3.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

2.8

—

3.92

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

2.8

—

108.20

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(4198724)

0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

2.9

—

5.73

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.6

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.0

2.3

—

1.21

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.7

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

-0.00

0.0

2.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.6

—

4.17

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_OTHER_CONGEN_MALFO_RESPI_SYSTEM and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_OTHER_CONGEN_MALFO_RESPI_SYSTEM.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: Q17_OTHER_CONGEN_MALFO_RESPI_SYSTEM – Other congenital malformations of respiratory system

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other congenital malformations of respiratory system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints